Amifostine Hydrate Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Amifostine Hydrate Market size is expected to grow at an annual average of 7% during 2022-2028. Amifostine hydrate is provided as a single dose vial of 500 mg for intravenous administration and must be reconstituted by injection of 9.7 ml sodium chloride (0.9%). The reconstituted mixture is stable for 5 hours at room temperature and 24 hours when stored in the refrigerator. It should be administered 30 minutes prior to chemotherapy, and blood pressure should be continuously monitored every 5 minutes during the infusion. The recommended dose to reduce cumulative nephrotoxicity is 910 mg/m2 15-minute infusion once daily, administered 30 minutes prior to chemotherapy, with continuous blood pressure monitoring every 5 minutes during the infusion. The recommended dose for dry mouth is 200 mg/m2 once daily, usually given 3 minutes before radiation therapy 15 minutes.

The following segmentation are covered in this report:

By Application

• Ovarian Cancer Adjuvant Therapy
• Head and Neck Cancer Adjuvant Therapy
• Others

By Type

• 400mg/Dose
• 500mg/Dose

Company Profile

• Clinigen Group
• Sun Pharmaceutical
• Taj Pharmaceuticals
• Merro Pharmaceutical
• Luye Pharma
• Mingren Pharma

Scope of the report

The research study analyses the Amifostine Hydrate Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Amifostine Hydrate Market Report

• What was the Amifostine Hydrate Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Amifostine Hydrate Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.